Software, genome sequencing, drug discovery and cloud platforms lead adoption, while precision medicine, diagnostics and AI-enabled services create new opportunities.Dublin, Oct. 19, 2026 (GLOBE ...
OptimUM-01 and OptimUM-02 data supports the broad potential of darovasertib plus crizotinib to drive meaningful clinical ...
Dublin, Oct. 19, 2026 (GLOBE NEWSWIRE) -- "Microarray Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. This market research report examines the global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results